• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCOVID-19 vaccines

A quarter of U.S. adults are now fully vaccinated. See how your state is doing

By
Erika Fry
Erika Fry
and
Nicolas Rapp
Nicolas Rapp
Down Arrow Button Icon
By
Erika Fry
Erika Fry
and
Nicolas Rapp
Nicolas Rapp
Down Arrow Button Icon
April 7, 2021, 7:06 PM ET

America’s COVID vaccine rollout has been far from perfect, but four months in—with three authorized vaccines available to an ever-widening share of the population, at settings ranging from retail pharmacies to health providers to mass vaccination sites—it’s going pretty well.

As of Wednesday, April 7, 110 million Americans—roughly a third of the population, and 42.4% of adults, had received at least one dose of a COVID vaccine, according to data from the Centers for Disease Control and Prevention. That number is up from 97.6 million people last Wednesday; on average, the U.S. Administered more than 3 million doses daily in the past week.

Nearly a quarter of all adults, a total of 64.3 million, and 57.4% of Americans over the age of 65, have been fully vaccinated. The vast majority of vaccinated individuals received one of the two-dose Pfizer or Moderna mRNA vaccines; about 4.5 million Americans have received the one-shot product developed by Johnson & Johnson.

In terms of states, New Hampshire has vaccinated the largest share of its population—43.6% of its residents have received at least one dose, according to CDC data; New Mexico has reached 41.4%. California, the nation’s most populous state, has administered 20.9 million vaccines and reached 35.1% of the population with one dose. Alabama and Mississippi, each of which has reached 26.3% of their residents with a coronavirus vaccine, have the lowest percentages. 

While the U.S. Rollout has picked up pace, efforts in Europe have been troubled this week by another revelation regarding the AstraZeneca COVID vaccine. European regulators on Wednesday said that while the vaccine is “probably the cause” of extremely rare blood-clotting incidents, the benefits of the vaccine’s use outweigh the risks. Production and supply issues are challenging the rollout elsewhere around the world.

Share of the population that has received at least once shot

State or territoryShare vaccinated
Alaska35.6%
Alabama26.3%
Arkansas29.2%
Arizona32.7%
California35.1%
Colorado34.4%
Connecticut39.7%
Wash. D.C.31.3%
Delaware35.4%
Florida31.2%
Georgia27.6%
Guam37.0%
Hawaii34.6%
Iowa34.2%
Idaho28.6%
Illinois35.1%
Indiana28.1%
Kansas34.8%
Kentucky34.0%
Louisiana28.1%
Massachusetts39.2%
Maryland35.3%
Maine39.3%
Michigan32.0%
Minnesota35.4%
Missouri29.0%
Mississippi26.3%
Montana33.7%
North Carolina31.6%
North Dakota34.8%
Nebraska34.3%
New Hampshire43.6%
New Jersey38.0%
New Mexico41.4%
Nevada30.4%
New York35.5%
Ohio32.8%
Oklahoma33.8%
Oregon32.0%
Pennsylvania35.4%
Puerto Rico24.5%
Rhode Island37.1%
South Carolina29.7%
South Dakota38.3%
Tennessee27.8%
Texas29.3%
Utah29.4%
Virginia35.7%
Virgin Islands25.7%
Vermont38.2%
Washington33.6%
Wisconsin35.7%
West Virginia32.1%
Wyoming29.2%
About the Authors
Erika Fry
By Erika Fry
LinkedIn iconTwitter icon
See full bioRight Arrow Button Icon
Nicolas Rapp
By Nicolas RappInformation Graphics Director
LinkedIn icon

Nicolas Rapp is the former information graphics director at Coins2Day.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.